NFRP Outreach and Invitation for Response

In plain English

Defense Health Agency Contracting Activity - DHACA (Department of Defense) has announced this as a forecast: an opportunity it expects to post. It is not open for applications yet.

The listing does not state award amounts or the number of awards.

Eligibility is listed as unrestricted (open to any type of applicant), subject to any clarification in the listing.

Cost sharing or matching is required.

Built only from the fields in the Grants.gov listing. Always confirm on the official listing.

• Unrestricted (open to any type of entity above, subject to clarification in the listing)

Excerpt from the official forecast on Grants.gov (shortened; read the full text on the official listing):

The Congressionally Directed Medical Research Program (CDMRP) Neurofibromatosis Research Program (NFRP) and the US Army Medical Research Acquisition Activity (USAMRAA) are exploring the possibility of pursuing a Research-based Other Transactions Agreement (rOTA) in accordance with 10 U.S.C. 2371 to support a major goal/product-driven team of exceptional institutions and investigators that will accelerate the clinical translation of basic NF research and ultimately decrease the impact of the disease. The objectives of the resulting rOTA shall be to conceive, design, develop, and conduct collaborative Phase I and II clinical evaluations of promising therapeutic agents for the management or treatment of NF1, NF2, and schwannomatosis. Historically, this requirement has been competed as an assistance agreement, with prior awards made as part of the FY06, FY11, and FY16 portfolios. …

Read the full forecast on Grants.gov →